Purple Biotech Ltd.
Purple Biotech Ltd. (PPBT) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · PPBT · as of Sep 30, 2025
Ownership Breakdown
14
Institutional Holders
▲ 2 vs Q2
$75,880
Total Inst. Value
▼ $57,797 vs Q2
138,084
Shares Outstanding
freeFloat 94.52%
132,662
13F Shares Held
▲ 75,663 vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
PPBT largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
VIRTU FINANCIAL LLC pharmaceutical preparations | 49.0K | 204.12% | 204.12% | $28.00M | Nov 14, 2025 | NEW |
CITADEL ADVISORS LLC pharmaceutical preparations | 41.3K | 171.88% | 171.88% | $23.53M | Nov 14, 2025 | NEW |
GAMMA INVESTING LLC pharmaceutical preparations | 12.7K | 52.72% | 52.72% | $7.27M | Oct 2, 2025 | ▲ 8.2K |
BNP PARIBAS ARBITRAGE, SNC pharmaceutical preparations | 11.3K | 46.97% | 46.97% | $6.47M | Nov 13, 2025 | ▲ 5.0K |
MORGAN STANLEY pharmaceutical preparations | 11.1K | 46.10% | 46.10% | $6.36M | May 27, 2026 | ▲ 6.5K |
UBS GROUP AG pharmaceutical preparations | 5.9K | 24.78% | 24.78% | $3.41M | Nov 13, 2025 | ▼ 17.2K |
RHUMBLINE ADVISERS pharmaceutical preparations | 1.1K | 4.50% | 4.50% | $614,000 | Nov 6, 2025 | — held |
TRADEWINDS CAPITAL MANAGEMENT, LLC pharmaceutical preparations | 100 | 41.66% | 41.66% | $58,000 | Oct 21, 2025 | NEW |
ADVISORY SERVICES NETWORK, LLC pharmaceutical preparations | 99 | 41.25% | 41.25% | $57,000 | Nov 18, 2025 | NEW |
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO pharmaceutical preparations | 85 | 35.41% | 35.41% | $49,000 | Nov 14, 2025 | — held |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
4
Increased
+19.8K shares4
New Positions
first time holders1
Decreased
−17.2K shares2
Sold Out
fully exitedNet shares change (top 50)
+2.6K
+19.8K / −17.2K
Net new holders
+5
4 new / 2 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
PPBT insider trading · insider activity
Source: SEC Form 4
0
Buy transactions
0
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
No recent insider transactions reported.
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Purple Biotech Ltd. (PPBT) is primarily owned by institutional investors, who hold approximately 96.1% of total shares outstanding. Company insiders own approximately 5.48%, while retail and public investors account for the remaining 0.00%.
The largest institutional shareholder of Purple Biotech Ltd. is VIRTU FINANCIAL LLC, holding approximately 48,993 shares — equal to 204.12% of outstanding shares — as of September 30, 2025.
A total of 14 institutional investors currently hold PPBT stock, with a combined institutional value of approximately $75,880 as of the most recent 13F filing period.
Frequently asked questions
PPBT ownershipPurple Biotech Ltd. (PPBT) is primarily owned by institutional investors, who hold approximately 96.1% of shares. The largest shareholder is VIRTU FINANCIAL LLC with a 204.12% stake. Company insiders hold 5.48%. Data sourced from SEC Form 13F as of September 30, 2025.